Skip to main content

Chronic inflammatory bowel diseases (IBD)

Due to the damaged or sore intestinal wall, the nutrient uptake in patients with chronic inflammatory bowel diseases (Crohn's disease, ulcerative colitis) is reduced and the nutrient loss is increased. Patients with IBD also suffer increasingly from food intolerances and allergies due to chronic inflammation. The increased loss of nutrients combined with an increased demand often leads to a deficit of vital macro- and micro nutrients. At the same time, the intolerance reactions do not only lead to an increase in abdominal pain, but also to a further restriction of food intake if an appropriate elimination diet is followed. As a result, malnutrition and a muscular loss develop. The consequences are physical weakness and fatigue. Any protein loss also worsens wound healing and promotes secondary infections, worsening the patient's prognosis.

 Particularly in the inflammatory phases of IBD, muscle- and weight loss occur, whereby the muscle function (strength and endurance) may also be reduced in patients in remission. Due to the loss of muscle mass and function, patients are very limited in their mobility, muscle strength and endurance and show a reduced quality of life.

Our goal is therefore to improve the nutritional situation and prognosis of the patient with a combined nutrition and exercise therapy. Furthermore, it is attempted to modulate the microbiome through an adapted nutritional and probiotic therapy (e.g. E. coli Nissle) and to reduce the inflammatory activity in the intestine.